Bone Solutions Inc. has been awarded its fifth U.S. patent this year related to Mg OSTEOCRETE. The patent portfolio includes current and future configurations, as well as novel delivery systems.

The five patents further expand Bone Solutions’ industry footprint and allow surgeons and patients to further benefit from the advantages of the Bone Solutions proprietary magnesium-based technology, according to the company. Mg OSTEOCRETE and Mg OSTEOINJECT (an injectable version of the product) are fast-setting bone substitutes that remodel into bone over time through creeping substitution, meaning they provide needed support to the defect or void during the healing process while transforming into bone at an optimal rate.

“We are pleased to announce the addition of five new patents supplementing our various technologies, ensuring our continued growth and profitability for the company’s future,” Bone Solutions CEO Drew Diaz said. “By leveraging our existing technology, Bone Solutions is furthering its mission to improve patient outcomes through our superior magnesium-based orthopedic solutions.”

Mg OSTEOCRETE’s magnesium component is the significant differentiator from other bone substitutes on the market, company executives claim. The crystallization reaction from magnesium oxide and the blend of phosphate-based materials allows for the product’s ideal osteoconductivity. As a result, Mg OSTEOCRETE and Mg OSTEOINJECT set and cure in situ without migration. The material stimulates cell adhesion, proliferation, and formation of the bone extracellular matrix by osteoblast cells, thus promoting bone growth.

In addition to the superior biological performance of the material, the handling characteristics and formulation are ideal for clinical use. Ready for use after only 30 seconds of mixing, the material is moldable or injectable and is cohesive and adhesive to the area it fills. Once implanted, the material sets quickly, is drillable after only two minutes, and is also radiopaque.

Mg OSTEOCRETE and Mg OSTEOINJECT are currently being distributed to facilities and surgical centers nationwide for immediate clinical use.

Bone Solutions Inc. is a specialized medical device company improving clinical outcomes through biologically safe, fully resorbable magnesium-based orthopedic implant solutions, with a focus on addressing complex procedures and cost reduction. The Colleyville, Texas-based company is developing various new orthopedic technologies within its U.S. Food and Drug Administration-cleared magnesium-based platform.